SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-20-046179
Filing Date
2020-10-09
Accepted
2020-10-09 13:08:21
Documents
12
Period of Report
2020-10-05
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K srne-8k_20201005.htm   iXBRL 8-K 38588
  Complete submission text file 0001564590-20-046179.txt   163368

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA srne-20201005.xsd EX-101.SCH 5736
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE srne-20201005_lab.xml EX-101.LAB 18717
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE srne-20201005_pre.xml EX-101.PRE 11128
5 EXTRACTED XBRL INSTANCE DOCUMENT srne-8k_20201005_htm.xml XML 3418
Mailing Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121
Business Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121 858-203-4100
Sorrento Therapeutics, Inc. (Filer) CIK: 0000850261 (see all company filings)

IRS No.: 330344842 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36150 | Film No.: 201232723
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences